/FFNT.CN
FFNT.CN Stock - 4Front Ventures Corp.
Healthcare|Drug Manufacturers - Specialty & GenericCNQ
$0.01+0.00%
+$0.00 (+0.00%) • May 7
51
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.81
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FFNT.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.00
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.96
52W High$0.20
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $97.44M | $107.66M | $104.57M | $57.63M | $19.03M |
| Gross Profit | $45.89M | $51.42M | $49.40M | $36.51M | $8.18M |
| Gross Margin | 47.1% | 47.8% | 47.2% | 63.3% | 43.0% |
| Operating Income | $-20,847,000 | $-15,020,000 | $-13,874,000 | $-32,610,000 | $-179,840,000 |
| Net Income | $-91,647,000 | $-46,898,000 | $-38,309,000 | $-47,051,000 | $-182,010,000 |
| Net Margin | -94.1% | -43.6% | -36.6% | -81.6% | -956.3% |
| EPS | $-0.07 | $-0.07 | $-0.06 | $-0.09 | $-0.43 |
Company Overview
4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates in two segments, THC Cannabis and Cannabidiol (CBD) Wellness. It produces, cultivates, sells, and distributes cannabis and CBD. As of December 31, 2021, it operated six dispensaries in Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. In addition, the company sells equipment, supplies, and intellectual property to cannabis producers; imports and sale equipment and supplies; leases real estate properties to cannabis producers; offers consulting services; and operates cannabis dispensaries. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
FFNT.CNBeat Rate
0%
Last 4 quarters
Avg Surprise
-89.9%
EPS vs Estimate
Beats / Misses
0/4
Last 12 quarters
Latest EPS
$-0.01
Q4 2024
EPS Surprise History
Q1 23
No data
Q1 23
-105.0%
$-0.04vs$-0.02
Q3 23
-77.1%
$-0.02vs$-0.01
Q4 23
No data
Q1 24
No data
Q2 24
-127.3%
$-0.03vs$-0.01
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 12, 2025 | — | — | — | — |
Q3 2025 | Aug 18, 2025 | — | — | — | — |
Q2 2025 | May 16, 2025 | — | — | — | — |
Q2 2025 | Apr 17, 2025 | — | — | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 15, 2024 | $-0.01 | $-0.03 | -127.3% | ✗ MISS |
Q1 2024 | Mar 28, 2024 | — | $-0.01 | — | — |
Q4 2023 | Nov 20, 2023 | — | $-0.13 | — | — |
Q3 2023 | Aug 15, 2023 | $-0.01 | $-0.02 | -77.1% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.02 | $-0.04 | -105.0% | ✗ MISS |
Q1 2023 | Mar 28, 2023 | — | $-0.05 | — | — |
Q4 2022 | Nov 14, 2022 | $-0.01 | $-0.01 | -49.9% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | — | $-0.01 | — | — |
Q2 2022 | May 23, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 30, 2022 | — | $-0.02 | — | — |
Q4 2021 | Nov 17, 2021 | — | $-0.01 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 24, 2021 | — | $-0.02 | — | — |
Q2 2021 | Apr 6, 2021 | — | $-0.07 | — | — |
Latest News
Loading news...
Frequently Asked Questions about FFNT.CN
What is FFNT.CN's current stock price?
4Front Ventures Corp. (FFNT.CN) is currently trading at $0.01 per share. The stock has moved +0.00% today.
What is the analyst price target for FFNT.CN?
No analyst price targets are currently available for this stock.
What sector is 4Front Ventures Corp. in?
4Front Ventures Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.
What is FFNT.CN's market cap?
4Front Ventures Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does FFNT.CN pay dividends?
No, 4Front Ventures Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBAMM.CN
Body and Mind Inc.
$0.03
Mkt Cap: $0.0B
BCBC.CN
The BC Bud Corporation
$0.04
Mkt Cap: $0.0B
BHNG.CN
Bhang Inc.
$0.02
Mkt Cap: $0.0B
CANN.CN
Heritage Cannabis Holdings Corp.
$0.01
Mkt Cap: $0.0B
CMND.CN
Clearmind Medicine Inc.
$1.60
Mkt Cap: $0.0B
FH.NE
Filament Health Corp.
$0.01
Mkt Cap: $0.0B
LUFF.CN
Luff Enterprises Ltd.
$0.01
Mkt Cap: $0.0B
MSVN.CN
ManifestSeven Holdings Corporation
$0.02
Mkt Cap: $0.0B
THC.CN
THC Biomed Intl Ltd.
$0.02
Mkt Cap: $0.0B
WLLW.TO
Willow Biosciences Inc.
$0.04
Mkt Cap: $0.0B
Explore stocks similar to FFNT.CN for comparison